Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD

World News: . []

LIVONIA Mich Aug 10 2018 GLOBE NEWSWIRE -- Gemphire Therapeutics Inc NASDAQ GEMP a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders including dyslipidemia and n onalcoh...

More news and information about Gemphire Therapeutics Inc.

Published By:

Globe Newswire: 11:00 GMT Friday 10th August 2018

Published: .

Search for other references to "gemphire" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us